CHRNA5 and neoplasm: To date, studies investigating the CHRNA5-A3-B4 polymorphisms in relation to tumor clinical stage have been few; however, it has been proposed that nicotine after initiation may contribute to the progression phase of cancer development because nicotine promotes the growth of cancer cells and the proliferation of endothelial cells in vivo [36].